🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced Apr 1

Find Clinical Trials for Your Rare Disease

34+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data
Clear

Showing 14 of 34 recruiting trials for “choroidal-osteoma

Phase 3RecruitingNCT06519266

PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases

👨‍⚕️ Roger Olofsson Bagge, Professor, Sahlgrenska Universitetssjukhuset📍 6 sites📅 Started Jun 2024View details ↗
Phase 3RecruitingNCT06007690

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

👨‍⚕️ Medical Monitor, Aura Biosciences📍 71 sites📅 Started Dec 2023View details ↗
RecruitingNCT05733728

Retrospective Register for Uveal Melanoma

🏥 Medical University of Vienna📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05524935

Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma

👨‍⚕️ Nikhil I Khushalani, MD, Moffitt Cancer Center📍 1 site📅 Started Oct 2022View details ↗
Phase 3RecruitingNCT05502900

Adjuvant Melatonin for Uveal Melanoma

👨‍⚕️ Gustav Stålhammar, MD PhD, St. Erik Eye Hospital and Karolinska Institutet📍 1 site📅 Started Oct 2022View details ↗
Phase 1RecruitingNCT05496686

Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma

👨‍⚕️ Mark L McLaughlin, Modulation Therapeutics, Inc.📍 1 site📅 Started Jul 2022View details ↗
Phase 2RecruitingNCT05077280

A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma

👨‍⚕️ David R Minor, MD, California Pacific Med Center Research Inst.📍 1 site📅 Started Sep 2021View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT05893654

Melphalan Chemoreduction for Ocular Melanoma

👨‍⚕️ Rodrigo Jorge, MD, PhD, Professor of Ophthalmology📍 1 site📅 Started May 2021View details ↗
Phase 1RecruitingNCT04855435

Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours

👨‍⚕️ Kristoffer S Rohrberg, MD PhD, University Hospital of Denmark, Department of Oncology📍 5 sites📅 Started Apr 2021View details ↗
Phase 1, PHASE2RecruitingNCT04729543

MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer

🏥 Erasmus Medical Center📍 1 site📅 Started Oct 2020View details ↗
NARecruitingNCT04424719

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

👨‍⚕️ Sophie Piperno-Neumann, MD, Institut Curie📍 1 site📅 Started Jul 2020View details ↗
RecruitingNCT03941379

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

👨‍⚕️ Medical Monitor, Aura Biosciences Inc.📍 16 sites📅 Started Mar 2019View details ↗
RecruitingNCT05377957

Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients

👨‍⚕️ Nanda Horeweg, Md PhD, Leiden University Medical Center📍 1 site📅 Started Mar 2019View details ↗
RecruitingNCT01438658

Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma

👨‍⚕️ Shahar Frenkel, MD, PhD, Hadassah Medical Organization📍 1 site📅 Started Sep 2011View details ↗
← PreviousPage 2 of 2

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →